Sub-Q Bionics, Inc
Medtech startup developing an implantable device intended to mechanically assist lymphatic circulation for treatment of lymphedema, with a clinical focus on women affected by cancer-related lymphatic damage. The team combines medical device engineering, clinical advisory input from plastic and vascular surgeons and physiotherapists, and early-stage investor engagement.
Industries
N/A
Nr. of Employees
small (1-50)
Sub-Q Bionics, Inc
Locations: Minnesota, USA & Tel Aviv, Israel
Products
Implantable bionic lymphatic pump (development-stage)
A development-stage implantable device intended to mechanically assist lymphatic circulation and provide continuous fluid management for patients with lymphedema.
Implantable bionic lymphatic pump (development-stage)
A development-stage implantable device intended to mechanically assist lymphatic circulation and provide continuous fluid management for patients with lymphedema.
Expertise Areas
- Implantable medical device development
- Lymphedema clinical management
- Women's health (oncology-related indications)
- Medical device R&D and prototyping
Key Technologies
- Implantable mechanical pump systems
- Embedded device control and firmware
- Implantable biomedical device design
- Surgical implantation workflows
News & Updates
Company pitched at the Medtech MVP Pitch Contest during the Medtech MVP Conference in Minneapolis.
CEO attended Femtech event and Japan Health Conference to network with medtech entrepreneurs, investors, and advisors.
Academic article cited on the site regarding adherence factors for decongestion therapy in breast cancer-related lymphedema.
Company presented to investors at the Medtech MVP Pitch Contest 2025.
Company pitched at the Medtech MVP Pitch Contest during the Medtech MVP Conference in Minneapolis.
CEO attended Femtech event and Japan Health Conference to network with medtech entrepreneurs, investors, and advisors.
Academic article cited on the site regarding adherence factors for decongestion therapy in breast cancer-related lymphedema.
Company presented to investors at the Medtech MVP Pitch Contest 2025.